ES2305272T3 - Procedimiento de purificacion a gran escala de globulina gc, producto obtenido por el mismo y su uso en medicina. - Google Patents

Procedimiento de purificacion a gran escala de globulina gc, producto obtenido por el mismo y su uso en medicina. Download PDF

Info

Publication number
ES2305272T3
ES2305272T3 ES02754557T ES02754557T ES2305272T3 ES 2305272 T3 ES2305272 T3 ES 2305272T3 ES 02754557 T ES02754557 T ES 02754557T ES 02754557 T ES02754557 T ES 02754557T ES 2305272 T3 ES2305272 T3 ES 2305272T3
Authority
ES
Spain
Prior art keywords
globulin
chromatography
exchange chromatography
purification
purification procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02754557T
Other languages
English (en)
Spanish (es)
Inventor
Charlotte Svaerke Jorgensen
Inga Laursen
Gunnar Houen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Statens Serum Institut
Original Assignee
Statens Serum Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Serum Institut filed Critical Statens Serum Institut
Application granted granted Critical
Publication of ES2305272T3 publication Critical patent/ES2305272T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
ES02754557T 2001-08-14 2002-08-12 Procedimiento de purificacion a gran escala de globulina gc, producto obtenido por el mismo y su uso en medicina. Expired - Lifetime ES2305272T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101217 2001-08-14
DK200101217 2001-08-14

Publications (1)

Publication Number Publication Date
ES2305272T3 true ES2305272T3 (es) 2008-11-01

Family

ID=8160667

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02754557T Expired - Lifetime ES2305272T3 (es) 2001-08-14 2002-08-12 Procedimiento de purificacion a gran escala de globulina gc, producto obtenido por el mismo y su uso en medicina.

Country Status (9)

Country Link
EP (1) EP1419177B1 (enExample)
JP (1) JP2005508892A (enExample)
AT (1) ATE393780T1 (enExample)
AU (1) AU2002321012B2 (enExample)
CA (1) CA2456843A1 (enExample)
DE (1) DE60226327T2 (enExample)
DK (1) DK1419177T3 (enExample)
ES (1) ES2305272T3 (enExample)
WO (1) WO2003016348A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1778301A2 (en) * 2004-06-29 2007-05-02 Reliance Life Sciences Pvt., Ltd. Process for improvement of virus-safe biological fluids
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
SG10201503899SA (en) * 2010-05-18 2015-06-29 Abbvie Inc Apparatus And Process Of Purification Of Proteins
JP5860401B2 (ja) 2010-09-03 2016-02-16 森田薬品工業株式会社 新規Ｇｃグロブリンガラクトース脱糖体の製造方法
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
PL3081221T3 (pl) 2013-12-13 2021-12-27 Saisei Pharma Co., Ltd. Kompozycja farmaceutyczna zawierająca produkt obróbki enzymatycznej siary bydlęcej
CN111632167B (zh) * 2014-04-15 2021-12-28 勃林格殷格翰国际公司 在制造生物制品期间连续灭活病毒的方法、装置和系统
PL3290043T3 (pl) * 2015-06-01 2023-07-03 Saisei Pharma Co., Ltd. Produkt mleczny poddany obróbce enzymatycznej, sposób jego wytwarzania, kompozycja i produkt

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177002A (en) * 1989-11-20 1993-01-05 Nobuto Yamamoto In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor
ES2124702T3 (es) * 1990-04-11 1999-02-16 Brigham & Womens Hospital Usos terapeuticos de compuestos que se unen a actina.
US6268478B1 (en) * 1996-02-12 2001-07-31 Cedars-Sinai Medical Center Intracellular vitamin D binding protein

Also Published As

Publication number Publication date
WO2003016348A3 (en) 2004-03-04
DE60226327T2 (de) 2009-07-09
EP1419177B1 (en) 2008-04-30
EP1419177A2 (en) 2004-05-19
DE60226327D1 (de) 2008-06-12
DK1419177T3 (da) 2008-08-25
JP2005508892A (ja) 2005-04-07
WO2003016348A2 (en) 2003-02-27
CA2456843A1 (en) 2003-02-27
ATE393780T1 (de) 2008-05-15
AU2002321012B2 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
US6806355B2 (en) Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
ES2527915T3 (es) Producto de inmunoglobulina G (IgG) líquido
EP2270044B1 (en) Liquid immunoglobulin G (lgG) product
JP2955211B2 (ja) ウイルスに関して安全なヒト免疫グロブリンａ単量体及びその製造方法
ES2213760T3 (es) Preparacion de globulina de suero inmunizante inyectable por via intravenosa con virus inactivado.
AU2002321012B2 (en) A purification process for large scale production of Gc-globulin, product obtained thereby and their use in medicine
ES2272067T3 (es) Procedimiento de purificacion para la produccion de lecitina de union a manano y un producto medicinal de mbl.
AU2002321012A1 (en) A purification process for large scale production of Gc-globulin, product obtained thereby and their use in medicine
ES2379157T3 (es) Procedimiento para el aislamiento de haptoglobina.
JPH01207244A (ja) 血小板減少症治療剤
Lee Joergensen et al.
Aghaie et al. Preparation, purification and virus inactivation of intravenous immunoglobulin from human plasma
HK1151045B (en) Liquid immunoglobulin g (lgg) product
HK1151044B (en) Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products
SK37589A3 (en) Method for the separation of lipoproteins from blood gammaglobulin solution